MUSTANG BIO, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
95 SAWYER RD, WALTHAM, MA, 02453
Mailing Address
95 SAWYER RD, WALTHAM, MA, 02453
Phone
7816524500
Fiscal Year End
1231
EIN
473828760
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 19, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | December 3, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 7, 2025 | View on SEC |
| 4 Insider stock transaction report | October 1, 2025 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Developing innovative cell and gene therapies for hard-to-treat cancers and rare diseases.
- Active product pipeline with candidates in various clinical stages (Phase 1, 2, 3).
Insider Trading
SELL
3 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.